FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Sana Kliniken AG
Hospital
Location:
Ismaning (head quarters), Germany (DE)
ISNI
: 000000405583380
Publications
(121)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Laparoscopic right hemicolectomy with CME: standardization using the "critical view" concept (2018)
Strey CW, Wullstein C, Adamina M, Agha A, Aselmann H, Becker T, Grützmann R, et al.
Journal article
IL-23 is centrally involved in mediating molecular resistance to anti-TNF therapy in Crohn's disease patients (2018)
Schmitt H, Billmeier U, Dieterich W, Rath T, Sonnewald S, Reid S, Hirschmann S, et al.
Conference contribution
Treatment of diabetes in old age — individualisation mandatory! 5 Faustregeln für die Behandlung betagter Diabetiker (2017)
Zeeh J, Zeyfang A, Heppner HJ
Journal article, Review article
Antibacterial Effect of a 4x Cu-TiO2 Coating Simulating Acute Periprosthetic Infection-An Animal Model (2017)
Mauerer A, Stenglein S, Schulz-Drost S, Schoerner C, Taylor D, Krinner S, Heidenau F, et al.
Journal article
Efficacy and safety of Hybrid-APC for the ablation of Barrett’s esophagus (2016)
Manner H, May A, Kouti I, Pech O, Vieth M, Ell C
Journal article
Erratum to: Efficacy and safety of Hybrid-APC for the ablation of Barrett’s esophagus (Surg Endosc, DOI 10.1007/s00464-015-4336-1) (2016)
Manner H, May A, Kouti I, Pech O, Vieth M, Ell C
Journal article, Erratum
Randomized, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple negative or luminal B/HER2 normal breast cancer (GENEVIEVE) (2016)
Paepke S, Huober J, Sherko K, Eidtmann H, Untch M, Costa SD, Blohmer JU, et al.
Conference contribution
Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer - The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29) (2016)
Von Minckwitz G, Rezai M, Tesch H, Huober J, Gerber B, Zahm DM, Hilfrich J, et al.
Journal article
Biosimilars in inflammatory bowel disease (2016)
Siegmund B, Atreya R, Bokemeyer B, Kruis W, Mudter J, Sander C, Schreiber S, et al.
Journal article
Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases (2016)
De With K, Allerberger F, Amann S, Apfalter P, Brodt HR, Eckmanns T, Fellhauer M, et al.
Journal article
‹
1
...
9
10
11
12
13
›